Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Administrative Information / Disclaimer of Endorsement and Liability

Disclaimer of Endorsement and Liability

Official policies of the Early Detection Research Network.

Neither the National Cancer Institute (NCI) nor does the Early Detection Research Network (EDRN) endorse or recommend any commercial products, processes, or services. Therefore, mention of commercial products, processes, or services on EDRN's web site, edrn.nic.nih.gov, cannot be construed as an endorsement or recommendation.

The EDRN web site provides links to other internet sites for informational purposes and the convenience of its users. When users select a link to an external web site, they are leaving the EDRN web site and are subject to the privacy and security policies of the owners/sponsors of the external site.

Neither NCI nor EDRN endorse organizations that sponsor linked, external web sites. In addition, neither NCI nor EDRN endorse products or services that such organizations may offer. Furthermore, neither NCI nor EDRN control or guarantee the currency, accuracy, relevance, or completeness of information found on linked, external web sites.

Neither NCI nor EDRN can authorize the use of copyrighted materials published on linked, external web sites. Users must request authorization from the sponsors of those web sites.

Neither NCI nor EDRN is not responsible for transmissions users may receive from linked, external web sites.

Neither NCI nor EDRN guarantee that linked, external web sites comply with Section 508 (Accessibility Requirements) of the Rehabilitation Act.

Press releases or other materials meant for public use will not be posted on the EDRN web site unless developed by or for NCI, for EDRN, or for the National Institutes of Health.

In general, it is neither NCI's nor EDRN's intention to provide specific medical advice to users of its web site, but rather to provide users with information to help them better understand their health, diagnosed conditions, and the current range of approaches related to cancer treatment, prevention, screening, and supportive care. Both NCI and EDRN urge users to consult with a qualified physician for diagnosis and for answers to their personal medical questions.

Announcement 11/20/2014

New Round of EDRN FOAs

The RFAs for EDRN have been released:
- Biomarker Developmental Laboratories (U01),
- Clinical Validation Centers (U01),
- Biomarker Reference Laboratories (U24),
- Data Management and Coordinating Center (U24).

EDRN Renewal flyer NOTE-New receipt deadline for applications submitted for all EDRN FOAs is January 20, 2015, by 5:00 PM local time of applicant organization.

There will be a Pre-Application webinar to discuss each of the four individual EDRN FOAs on Tuesday, December 2nd, 2014, from 1pm-5pm (Eastern). Potential applicants interested in participating in the webinar should send a message to Dr. Sharmistha Ghosh (ghoshjanjigias@mail.nih.gov) no later than 5:00 p.m. (EST) November 21, 2014. Please mention the FOA of interest in the subject line.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.